Molecular and Vascular MRI of Placenta Accreta
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3R01HD094347-03S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$156,621Funder
National Institutes of Health (NIH)Principal Investigator
Ananth V AnnapragadaResearch Location
United States of AmericaLead Research Institution
Baylor College Of MedicineResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
An understanding of the transplacental transport of the SARS-CoV-2 virion is of enormous importance.Objective characterization of virion transport, even in animal models, is a hugely challenging task. Usingtransplacental transport as an example, we seek to address this problem: we will design and build a VirionSurrogate Particle (VSP). Binding of the VSP to target receptors (ACE2), and subsequent internalization willbe validated in cell culture, followed by in vivo testing of transplacental transport. The specific aims for thissupplement are thereore: 1. Prepare Virus Surrogate Particles (VSP), recapitulating the viral lipid envelope, bearing the Spike protein S on the surface and carrying proteolytic Furin in the lumen, and validate binding of VSP to the ACE2 receptor in cell culture studies. 2. Study trans-placental transport of VSP in the k18-hACE2 mouse model with the humanized ACE2 receptor throughout the course of pregnancy using MR, CT and fluorescence tracing of particles 3. Study the effect of known ACE2 receptor level effectors (low protein diet, hypertension, high fat diet) on transplacental transport of VSP